Prussian Blue Nanoparticles in Simulated Biological Fluids: Insights into Stability and Cytocompatibility toward Biomedical Applications
Source abstract
Abstract
International audience
Only a short abstract or summary was supplied by the source.
Source: openalex_inverted_index · Quality: short
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS
University of Strasbourg Institute of Advanced Study (USIAS)
Funding
Agence Nationale de la Recherche · Centre National de la Recherche Scientifique · China Scholarship Council · Jean-Marie Lehn Foundation
References (40)
Show source-provided references
1. 10.1016/j.cej.2024.15295310.1016/j.cej.2024.152953 ↗
2. 10.3390/ijms2211599310.3390/ijms22115993 ↗
3. 10.1016/j.actbio.2023.12.04710.1016/j.actbio.2023.12.047 ↗
4. 10.1016/j.ccr.2023.21541410.1016/j.ccr.2023.215414 ↗
5. 10.1039/D2QI01068B10.1039/D2QI01068B ↗
6. 10.1021/acsnano.6b0599010.1021/acsnano.6b05990 ↗
7. 10.1021/jacs.5b1207010.1021/jacs.5b12070 ↗
8. 10.1021/acsami.8b1034510.1021/acsami.8b10345 ↗
9. 10.1016/j.jcis.2024.10.00810.1016/j.jcis.2024.10.008 ↗
10. 10.1038/s41467-019-12429-610.1038/s41467-019-12429-6 ↗
11. 10.1021/acsnano.7b0351910.1021/acsnano.7b03519 ↗
12. 10.1021/bc500279w10.1021/bc500279w ↗
13. 10.1039/b923184f10.1039/b923184f ↗
14. 10.1016/j.colsurfb.2023.11337310.1016/j.colsurfb.2023.113373 ↗
15. 10.3390/nano1416133610.3390/nano14161336 ↗
16. 10.1186/s12989-023-00529-710.1186/s12989-023-00529-7 ↗
17. 10.2217/nnm-2020-019110.2217/nnm-2020-0191 ↗
18. 10.1002/adhm.20180034710.1002/adhm.201800347 ↗
19. 10.1016/j.drudis.2020.05.01410.1016/j.drudis.2020.05.014 ↗
20. 10.1016/j.colsurfa.2010.06.00810.1016/j.colsurfa.2010.06.008 ↗
21. 10.1016/j.biomaterials.2014.09.00410.1016/j.biomaterials.2014.09.004 ↗
22. 10.1021/ic048843510.1021/ic0488435 ↗
23. 10.1002/advs.20170027710.1002/advs.201700277 ↗
24. 10.1002/cnma.20210022610.1002/cnma.202100226 ↗
25. 10.1016/j.ijpharm.2017.05.02610.1016/j.ijpharm.2017.05.026 ↗
26. 10.1080/10408444.2021.190338610.1080/10408444.2021.1903386 ↗
27. 10.3390/molecules2306141410.3390/molecules23061414 ↗
28. 10.1002/anie.20110519010.1002/anie.201105190 ↗
29. 10.14227/DT180311P1510.14227/DT180311P15 ↗
30. 10.1016/j.micromeso.2010.01.00910.1016/j.micromeso.2010.01.009 ↗
31. 10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
32. 10.1016/j.jconrel.2016.06.01710.1016/j.jconrel.2016.06.017 ↗
33. 10.1039/C9CE00757A10.1039/C9CE00757A ↗
34. 10.1021/acs.langmuir.3c0030710.1021/acs.langmuir.3c00307 ↗
35. 10.1016/j.ijpharm.2022.12200410.1016/j.ijpharm.2022.122004 ↗
36. 10.3390/ph1508097510.3390/ph15080975 ↗
37. 10.1007/s40089-017-0221-310.1007/s40089-017-0221-3 ↗
38. 10.1016/j.mtbio.2024.10125510.1016/j.mtbio.2024.101255 ↗
39. 10.1002/smll.20231034210.1002/smll.202310342 ↗
40. 10.1002/adfm.20240585610.1002/adfm.202405856 ↗